At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...
Prostate cancer is the most common malignant tumor in men, accounting for 29% of male neoplasm diagnoses in the United States alone. Radical prostatectomy remains the preferred treatment for localized ...
A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell ...
– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA ...
Original Medicare (parts A and B) covers medically necessary prostate surgeries, including treatments for an enlarged prostate and prostate cancer. Medicare covers various prostate procedures, ...
Morning Overview on MSN
A prostate cancer drug halved the odds of the disease spreading
Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...
Suffering from prostate cancer or benign prostatic hyperplasia (BPH) is not the end of a relationship. Technology and sexologists offer solutions to maintain erections and orgasms, even if ejaculation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results